Analyte-Specific Quality Controls Qualify a Blood Cannabinoid Study
The blood pharmacokinetic report disclosed different quality-control performance for different cannabinoids. Its THCCOOH-glucuronide control results warrant particular care when treating every reported concentration as equally precise.
One assay description contained several analytical procedures
The human study measured cannabinoids after smoked and vaporized cannabis. THC, 11-OH-THC and THCCOOH used solid-phase extraction, while THCCOOH-glucuronide used a liquid–liquid extraction procedure.
At the 2 ng/mL control concentration, reported percentage deviations for THCCOOH-glucuronide extended from −2.0% to 47.5%. At the 20 ng/mL control they extended from −11.1% to 23.5%. The paper reported ten glucuronide controls at each level, compared with sixteen for the other listed analytes.
A disclosed deviation is not a case-specific correction factor
These ranges show why the quality-control record should be read by analyte and concentration. They do not justify assuming that every participant’s glucuronide result had the largest positive deviation, subtracting that percentage from all results, or rejecting unrelated THC measurements automatically.
The report does not provide a simple universal adjustment that turns this range into each specimen’s measurement error. The appropriate qualification concerns the analytical uncertainty surrounding the specific analyte and method.
Keep the biological conclusion proportionate
A glucuronide concentration is a metabolite measurement, not a direct test of cognitive performance. Before emphasizing a small between-condition difference, a reviewer should consider the relevant control performance and the limited sample of seventeen infrequent users. This report arose from the same experiment as the linked acute-effects trial.
Related analysis: blood and oral-fluid patterns after inhaled cannabis.
Research cited
Spindle and colleagues (2019), Acute Pharmacokinetic Profile of Smoked and Vaporized Cannabis in Human Blood and Oral Fluid. DOI: 10.1093/jat/bky104.
